Rémy Gébleux Selected Research

Rémy Gébleux Research Topics

6	Neoplasms (Cancer) 01/2019 - 11/2015
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Leukemia 01/2017
1	Lymphoma (Lymphomas) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017

5	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 11/2015
3	Immunoglobulin G (IgG)IBA 10/2017 - 11/2015
3	Pharmaceutical PreparationsIBA 10/2017 - 11/2015
3	AntibodiesIBA 01/2017 - 11/2015
2	Cysteine (L-Cysteine)FDA Link 10/2017 - 11/2015
2	Cytotoxins (Cytolysins)IBA 01/2017 - 11/2016
2	AntigensIBA 01/2017 - 01/2017
2	monomethyl auristatin EIBA 01/2017 - 01/2017
2	Biological ProductsIBA 01/2017 - 01/2017
2	DipeptidesIBA 01/2017 - 01/2017
2	DisulfidesIBA 01/2017 - 11/2015
1	AnthracyclinesIBA 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Peptides (Polypeptides)IBA 10/2017
1	Peptide Hydrolases (Proteases)FDA Link 10/2017
1	Cathepsin BIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	TenascinIBA 01/2017
1	serum P-component (CIt)IBA 01/2017
1	Valine (L-Valine)FDA Link 01/2017
1	CitrullineIBA 01/2017
1	F8 monoclonal antibodyIBA 11/2015
1	Antineoplastic Agents (Antineoplastics)IBA 11/2015
1	Fibronectins (Fibronectin)IBA 11/2015
1	Maytansine (Maitansine)IBA 11/2015
1	Sulfhydryl Compounds (Thiols)IBA 11/2015
1	SIP(F8)-SS-DM1IBA 11/2015

3	Therapeutics 01/2019 - 11/2015
1	Drug Therapy (Chemotherapy) 11/2016
1	Intravenous Administration 11/2015